Please login to the form below

Not currently logged in
Email:
Password:

Just Health PR wins Caris Life Sciences brief

Bioscience company to launches its tumour profiling technology in Europe

Just Health PR has been appointed by US bioscience company Caris Life Sciences to help introduce their tumour profiling technology to European markets.

Caris' molecular intelligence (MI) service provides oncologists with clinically actionable, individualised treatment information for solid tumours.

Using a combination of technologies, including next-generation sequencing (NGS), Caris sifts a database of peer-review and published cancer research papers, in order to correlate specific biomarkers to positive drug responses.

By comparing the genetic and molecular makeup unique to each patient's tumour with data from existing clinical studies, GPs can determine the course of treatment likely to be most effective for the individual patient.

Leading the Just Health PR push will be the agency's head of political relations, Jon Spiers, who said: "This is an incredibly fast-moving and innovative area of medicine which is of great interest to politicians and policymakers.

"We are thrilled to be working on a technology, which has the potential to revolutionise the way we treat cancer."

Because MI is neither a treatment nor a diagnostic, there is no clear measure for assessing its utility within the NHS. However, the Just team has begun talks with the Department of Health, the Technology Strategy Board, the NHS Technology Adoption Centre and the Downing Street Policy Unit to determine how the health service might adopt the technology.

12th February 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics